Non-permissive SARS-CoV-2 infection in human neurospheres

Autor: Pedrosa, Carolina da S.G., Goto-Silva, Livia, Temerozo, Jairo R., Souza, Leticia R.Q., Vitória, Gabriela, Ornelas, Isis M., Karmirian, Karina, Mendes, Mayara A., Gomes, Ismael C., Sacramento, Carolina Q., Fintelman-Rodrigues, Natalia, Cardoso Soares, Vinicius, Silva Gomes Dias, Suelen da, Salerno, José A., Puig-Pijuan, Teresa, Oliveira, Julia T., Aragão, Luiz G.H.S., Torquato, Thayana C.Q., Veríssimo, Carla, Biagi, Diogo, Cruvinel, Estela M., Dariolli, Rafael, Furtado, Daniel R., Borges, Helena L., Bozza, Patrícia T., Rehen, Stevens, Moreno L. Souza, Thiago, Guimarães, Marília Zaluar P.

Publikováno v: In Stem Cell Research July 2021 54

WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2.

Autor: H. S. Aragão, Luiz Guilherme, Oliveira, Júlia T., Temerozo, Jairo R., Mendes, Mayara A., Alexandre Salerno, José, Pedrosa, Carolina S. G., Puig-Pijuan, Teresa, Veríssimo, Carla P., Ornelas, Isis M., Torquato, Thayana, Vitória, Gabriela, Sacramento, Carolina Q., Fintelman-Rodrigues, Natalia, da Silva Gomes Dias, Suelen, Cardoso Soares, Vinicius, Souza, Letícia R. Q., Karmirian, Karina, Goto-Silva, Livia, Biagi, Diogo, Cruvinel, Estela M.

Publikováno v: PeerJ; Oct2021, p1-21, 21p

Non-permissive SARS-CoV-2 infection in human neurospheres.

Autor: Pedrosa CDSG; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil., Goto-Silva L; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil., Temerozo JR; National Institute for Science and Technology on Neuroimmunomodulation (INCT/NIM), Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; Laboratory on Thymus Research, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Souza LRQ; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil., Vitória G; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil., Ornelas IM; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil., Karmirian K; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Mendes MA; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil., Gomes IC; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Sacramento CQ; Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Fintelman-Rodrigues N; Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Soares VC; Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; Program of Immunology and Inflammation, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Dias SDSG; Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Salerno JA; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Puig-Pijuan T; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.; Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Oliveira JT; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil., Aragão LGHS; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil., Torquato TCQ; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil., Veríssimo C; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Biagi D; Pluricell Biotech, São Paulo, SP, Brazil., Cruvinel EM; Pluricell Biotech, São Paulo, SP, Brazil., Dariolli R; Pluricell Biotech, São Paulo, SP, Brazil.; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America., Furtado DR; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil., Borges HL; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Bozza PT; National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Rehen S; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Souza TML; National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; Program of Immunology and Inflammation, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Guimarães MZP; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2021 Jun 17. Date of Electronic Publication: 2021 Jun 17.